HDAC8 and acute myeloid leukemia: Indeed, a recent study reported the efficacy of HDAC8 inhibition in combination with FLT3 inhibitor in suppressing FLT3-ITD+ AML cells, thus sustaining the potential of combination treatment employing HDACi and standard chemotherapy (Long et al., 2020).